Glucotrack Inc.
13F holders, Q3 2024 (September 30)7holders +4
4new positions
0sold out
$2.41avg. 13F price*
At the end of Q3 2024, 7 institutions reported holding Glucotrack Inc. in their 13F filings, up 4 from Q2 2024. 4 opened new positions and 0 sold out. The largest holders were Geode Capital Management, LLC ($65K), Alerus Financial NA ($33K) and Cetera Investment Advisers ($24K).
- Company
- Glucotrack Inc.
- CUSIP
- 45824Q606
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $68K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 28,124 shares bought and 3,007 shares sold, net +25,117 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Geode Capital Management, LLC | 0.00% | New | 27,161 | $65K |
| Alerus Financial NA | 0.00% | No change | 13,855 | $33K |
| Cetera Investment Advisers | 0.00% | No change | 10,000 | $24K |
| UBS Group AG | 0.00% | Reduce -49.4% | 3,085 | $7K |
| Morgan Stanley | 0.00% | New | 500 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 432 | $1K |
| Bank of America Corp. | 0.00% | New | 31 | $75 |
"% of holder's portfolio" is GLUCOTRACK INC's weight in each manager's 13F, not the share of Glucotrack Inc. the manager owns.